Christopher J. Cadham, PhD, MPH

Dr. Christopher Cadham is a health outcomes and health policy researcher working to identify policies and interventions that provide the highest value to society. A dedicated “team scientist,” Dr. Cadham uses a transdisciplinary and collaborative approach to his research which primarily focuses on cancer prevention, particularly understanding the role of individual behavior in cancer screening disparities. Recently, he and his collaborators found that by screening Black women for breast cancer a decade earlier, the Black/White mortality disparity in breast cancer could by reduced by 57%. Dr. Cadham has also worked extensively in the areas of smoking cessation and tobacco regulatory science and his work in this arena led to the FDA’s proposed rule in April 2022 to prohibit menthol cigarettes which they estimate could save 650,000 lives by 2060. As part of the Hutchinson Institute for Cancer Outcomes Research, or HICOR, Dr. Cadham weaves together policy-relevant modelling with methodological advances to highlight current practices that undermine health equity. He has received numerous awards for his research including a 2020 CISNET Award of Excellence for Outstanding Contributions to Research. Across all of his work, he aims to generate insights that provide policymakers with the information necessary to craft evidence-based, equitable and effective healthcare policies.